Optical Coherence Tomography Angiography (OCT-A) in Children (≥ 6 <14 Years of Age)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-31

Study Completion Date

2018-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of OCTA to conventional imaging modalities for the diagnosis of eye diseases in children

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)

NCT02811536

Retinal Disease

COMPLETED

High Resolution Optical Coherence Tomography

NCT05130385

Retinal Disease Retinal Detachment Retinal Vein Occlusion +13 more

UNKNOWN

Prevention of Onset and Transition to an Advanced Form of Diabetic Retinopathy in Children

NCT05615740

Diabetic Retinopathy

RECRUITING NA

Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module

NCT03530449

Retinal Vascular Normal Eyes

TERMINATED

Retinal Investigation Using Optos OCT Device

NCT06846151

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Optical coherence tomography angiography (OCTA) is a new non-invasive imaging technique that employs motion contrast imaging to high-resolution volumetric blood flow information. OCTA compares the decorrelation signal between sequential OCT b-scans taken at precisely the same cross-section in order to construct a map of blood flow. At present, level 1 evidence of the technology's clinical applications doesn't exist. The investigators plan to compare OCTA as an imaging modality to conventional imaging modalities used in clinical routine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinopathy of Prematurity Diabetic Retinopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

* Patients (children ≥ 6 \<14 years of age) from the Childrens Hospital, University Hospital Bern requiring routine internal medical check-up for the diagnosis of diabetes or children attending routine eye exams at the department of ophthalmology, who are willing to participate in the study, and whos parents are willing to sign informed consent on behalf of their child.
* Patients need to be at least 6 years of age (but younger than 14 years) 6 years of age or younger

Exclusion Criteria

* Patients (children) who are not willing or able to participate, or potential participant's parents who are not willing to sign informed consent on behalf of their child.
* Patients younger than 6 years of age or 14 years or older.
* Patients (children) with epilepsy

Minimum Eligible Age

6 Years

Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes